| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
2.33 0 (0%) |
07-10 16:00 |
|
Open: |
2.3 |
Pre close: |
2.33 |
Target:
|
3.01
|
|
High: |
2.34 |
Low: |
2.29 |
Resistance:
|
2.58
2.77
|
|
Volume: |
163,107 |
Market Cap: |
235M |
Support:
|
2.27
1.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.36
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
2.48  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.10 |
Stochastic Oscillator |
%K(14,3):
|
20.33 |
|
MA(250): |
2.73 |
%D(3): |
19.49 |
|
Average Volume(K) |
3-Month: |
20397
|
52-Week |
High:
|
3.82 |
|
10-Days: |
17858 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
44.83 |
Change(%): |
-27.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.479 |
Return on Equity (ttm) |
-42.2 |
Shares Out. (M) |
100.92 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-21.6 |
Shares Float (M) |
46.14 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.53 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.39 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.002 |
Shares Short (K) |
1580 |
|
Book Value (p.s.) |
0.700 |
EBITDA (p.s.) |
-0.374 |
P/E |
-4.86 |
|
Sales Per Share |
0.075 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.66 |
P/S |
31.19 |
|
Operating Margin |
-528.78 |
Levered Free Cash Flow
(M) |
-23.08 |
P/CF |
-10.38 |
|
|
|
|
|
|
